CD86 and neoplasm: Tumor-draining lymph nodes (TDLNs) of MC38 tumor-bearing C57BL/6 mice treated with PBS, OX+GA, OX-NCP, GA-NCP, or OX/GA were collected and analyzed for MHCII+CD86+ expressions in DCs (CD45+CD11b+CD11c+) 4 days after treatment.